wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38264533-936E74C5-2D2E-40A0-B0A2-671AD9636BA9
Q38264533-936E74C5-2D2E-40A0-B0A2-671AD9636BA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38264533-936E74C5-2D2E-40A0-B0A2-671AD9636BA9
Recent advances in vascular disrupting agents in cancer therapy.
P2860
Q38264533-936E74C5-2D2E-40A0-B0A2-671AD9636BA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38264533-936E74C5-2D2E-40A0-B0A2-671AD9636BA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00b5f91d4258fc39d540f8bc61fb43e3d2a80ebd
P2860
Phase I safety, pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent ombrabulin (AVE8062) in patients with advanced solid tumors.